Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 35,544 | reported | 04 Mar 2026 | tx 160+130,015−49,426 |
| Lexeo Therapeutics, Inc. | 14,583 | reported | 26 Jun 2025 | tx 2+50,583 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 289 | 321.82 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 215 | 320.81 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 102 | 320.01 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 767 | 323.84 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 272 | 324.88 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 350 | 323.01 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 106 | 319.03 USD | |
| 04 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 208 | 325.67 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 100 | 328.71 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 329 | 327.67 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 392 | 326.81 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 258 | 325.63 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 90 | 324.65 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 37 | 332.64 USD | |
| 02 Mar 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4,769 | 0.00 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 94 | 331.93 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 81 | 330.85 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 170 | 329.71 USD | |
| 02 Mar 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 47 | 323.62 USD | |
| 02 Mar 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 10,480 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 1,666 | 0.00 USD | |
| 27 Feb 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 1,666 | 0.00 USD | deriv |
| 13 Feb 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,959 | 310.08 USD | |
| 12 Feb 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4,000 | 0.00 USD | |
| 11 Jan 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 3,800 | 0.00 USD |